When is being in a hurry going too fast? Lessons learned from clinical trials in cervical cancer
- 30 April 2009
- journal article
- editorial
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 113 (1), 1-3
- https://doi.org/10.1016/j.ygyno.2009.02.015
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Efficacy and Patterns of Failure for Locally Advanced Cancer of the Cervix Treated With Celebrex (Celecoxib) and Chemoradiotherapy in RTOG 0128International Journal of Radiation Oncology*Biology*Physics, 2007
- Long-Term Follow-Up of a Randomized Trial Comparing Concurrent Single Agent Cisplatin, Cisplatin-Based Combination Chemotherapy, or Hydroxyurea During Pelvic Irradiation for Locally Advanced Cervical Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- A Phase II study of acute toxicity for Celebrex™ (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128International Journal of Radiation Oncology*Biology*Physics, 2007
- Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: A phase I/II study of the Gynecologic Oncology GroupGynecologic Oncology, 2006
- Weekly administration of topotecan–paclitaxel as second-line treatment in ovarian cancerCancer Chemotherapy and Pharmacology, 2006
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2006
- Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2005
- Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II studyCancer Chemotherapy and Pharmacology, 2004
- Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinomaGynecologic Oncology, 2004